Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/10/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Gary E. Frashier

Wrong Gary E. Frashier?

Strategic Partner

Phone: (650) ***-****  HQ Phone
SV Life Sciences
1700 Owens St Ste 184
San Francisco , California 94158
United States

Company Description: SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams. SV Life Sciences provides...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • B.S. , Chemical Engineering
    Texas Tech University
  • M.B.A.
    Massachusetts Institute of Technology
  • B.S , Chemical Engineering
    Texas Tech University
101 Total References
Web References
Board of Directors | Metric
metricmd.com, 10 Feb 2015 [cached]
Gary E. Frashier
Board of Directors
Mr. Frashier is President and Principal of Management Associates, and he brings extensive experience in life science management, operations and transactions, having served as a CEO for twenty-four years in life sciences and specialty chemicals. Prior to the founding of Management Associates, Mr. Frashier served as Chief Executive Officer and Chairman of OSI Pharmaceuticals, and it was during his tenure at OSI that the leading genetic-based cancer drug, "Tarceva" was discovered and developed thru initial human Proof of Concept clinical trials.
...
Mr. Frashier has raised over $250 million from a combination of equity financings and other sources, has organized many collaborations and joint programs with major pharmaceutical companies, and has served as a founder of several life science companies. Prior to OSI, Mr. Frashier served as President, International, and Executive Vice President of Millipore Corporation; President and CEO of Waters Corporation, the leader in liquid chromatography; and CEO of Genex Corporation, a protein engineering company. He has participated as a founder in organizing several biotechnology companies, including Merrimack Pharmaceuticals, Inc.; Eutropics, Inc.; America Stem Cell, Inc.; and Apex BioVentures Acquisition Corporation. He currently serves on the Board of Directors of Achillion Pharmaceuticals, Inc. (NASDAQ), ViroXis Corporation, Inc., and Metric Medical Devices, Inc., and he is an Advisor to Santalis Corporation and StemBioSys. He is a Strategic Partner in SV Life Sciences LP, a major venture capital company. He has served on numerous other private and public life science company Boards, including Maxim Pharmaceuticals, Tekmira Pharmaceuticals (Canada), Apex BioVentures Acquisition Corporation, Tanox, Inc., Cytoclonal Pharmaceuticals, Exegenics Pharmaceuticals, Aderis Pharmaceuticals, and Alseres Pharmaceuticals. Mr. Frashier has a B.S. in Chemical Engineering from Texas Tech University, which has designated him a "Distinguished Engineer Graduate," and an M.B.A. from the Massachusetts Institute of Technology, where he was selected as an "Alfred P. Sloan Fellow.
Achillion Pharmaceuticals: Board of Directors
www.achillion.com, 10 Mar 2015 [cached]
Gary E. Frashier
DIRECTOR
Mr. Frashier joined Achillion's Board of Directors in March 2008 and currently serves as Chair of the Compensation Committee and as a member of the Audit Committee.
Gary E. Frashier, age ...
www.sec.gov, 18 April 2014 [cached]
Gary E. Frashier, age 76. Mr. Frashier has served as a director of Achillion since March 2008 and currently serves as chair of our Compensation Committee and as a member of our Audit Committee. Mr. Frashier, through his company Management Associates, has been a strategic consultant to emerging growth companies in the life sciences field since 2000. From 1990 until 1998, he served as Chief Executive Officer of OSI Pharmaceuticals, Inc., a biotechnology company, and from 1997 until 2000, as its Chairman of the Board. From 1987 until 1990, he served as President and CEO of Genex Corporation, a protein engineering company, and from 1984 until 1987, as Chairman and CEO of Continental Water Systems, Inc., a manufacturer and marketer of equipment to produce high purity water used by the pharmaceutical, medical, electronics and research industries. Mr. Frashier also served as Executive Vice President of Millipore Corporation, a provider of products and services to biopharmaceutical, manufacturing, clinical, analytical and research laboratories, and as President of Millipore’s Waters Associates subsidiary. Mr. Frashier also serves on the Board of Directors of privately held Metric Medical Devices, a medical device company, StemBioSys, a stem cell technology company and Viroxis Corporation, a biopharmaceutical company. Mr. Frashier received a B.S. in Chemical Engineering from Texas Tech University and received his M.B.A. from the Massachusetts Institute of Technology, where he was a Sloan Fellow. Mr. Frashier’s qualifications include extensive managerial, manufacturing and merger and acquisition experience as a chief executive officer of multiple life sciences industry companies. As a director with several emerging technology companies, and as a consultant in the industry, Mr. Frashier also provides extensive experience in compensation management, alliance management and strategy development, all of which enhances his value on our Board.
ViroXis - Management & Partners
www.viroxis.com, 21 Mar 2015 [cached]
Gary E. Frashier
Director
Mr. Frashier is President and Principal of Management Associates, and brings extensive experience in Life science management, operations and transactions having served as a CEO for twenty four years, mostly in this area.
America Stem Cell
www.americastemcell.com, 4 Feb 2012 [cached]
Gary Frashier, M.B.A Executive Chairman of the Board & Co-Program/Project Team Leader for the ASC 101 Development Program
Gary is the President and Principal of Management Associates and brings extensive experience in life science company transactions and commercial operations. Prior to founding Management Associates in 1999, Mr. Frashier served as President and Chief Executive Officer of OSI Pharmaceuticals, a drug discovery company, from 1990 through 1998, and also as its Chairman of the Board from 1997 to 2000. During his tenure at OSI, the leading cancer drug "Tarceva" was discovered by OSI and it is now sold together with Genentech and Roche. Gary was instrumental in establishing strategic alliances with Pfizer, Hoechst, Sankyo, Roche and American Home Products and raised over $150 million from a combination of equity financings, grant awards, milestone payments and up-front fees.
Other People with the name "Frashier":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304